Polyarthritis in Sjögren's Syndrome: Difficulties in Distinguishing Extraglandular Manifestation and Associated Rheumatoid Arthritis

被引:0
作者
Aradi, Zsofia [1 ]
Nagy, Gabor [2 ]
Horvath, Ildiko Fanny [1 ]
Antal-Szalmas, Peter [2 ]
Szanto, Antonia [1 ]
机构
[1] Univ Debrecen, Inst Internal Med, Fac Med, Div Clin Immunol, H-4032 Debrecen, Hungary
[2] Univ Debrecen, Fac Med, Dept Lab Med, H-4032 Debrecen, Hungary
关键词
Sj & ouml; gren's syndrome; associated rheumatoid arthritis; polyarthritis; extraglandular manifestation; PRIMARY SJOGRENS-SYNDROME; RHEUMATOLOGY/EUROPEAN LEAGUE; ARTICULAR MANIFESTATIONS; CLASSIFICATION CRITERIA; AMERICAN-COLLEGE; MANAGEMENT;
D O I
10.3390/diagnostics14141494
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim of the study was to investigate the demographic data and disease course characteristics of patients with Sj & ouml;gren's syndrome (SS) and inflammatory joint pain of various origins and to search for factors that might help with the distinction of polyarthritis as an extraglandular manifestation and rheumatoid arthritis as an associated systemic autoimmune disorder. A total of 355 patients were retrospectively analyzed, 128 of whom served as controls (SS-C), while 159 had polyarthritis as an extraglandular symptom of Sj & ouml;gren's syndrome (SS-pa) and 68 were diagnosed as having associated rheumatoid arthritis (SS-RA). The patients without any inflammatory joint manifestations were significantly older than the SS-pa patients, while, for the SS-RA group, the difference was not significant. The onset of joint pain appeared significantly earlier in the SS-RA patients. Regarding either extraglandular manifestations or associated autoimmune disorders, there were significant differences between the controls and both SS-pa and SS-RA groups, while no significant difference was found between the SS-pa and SS-RA groups. Thus, laboratory and imaging methods should be used to differentiate between the two conditions, but laboratory biomarkers are even more important for early diagnosis. A ROC curve analysis showed an acceptable diagnostic accuracy in differentiating between SS-pa and SS-RA patients using a binary logistic regression model, where highly positive rheumatoid factor (RF) and anti-cyclic citrullinated peptide (CCP) values, kidney involvement, and anti-Ro/SS-A positivity were shown to significantly raise the odds of having RA, whereas anti-La/SS-B positivity seemed to have a protective role, since it significantly decreased the odds of having it. Further biomarkers are needed to better classify SS patient cohorts with inflammatory joint pain of different origins and, consequently, different management requirements.
引用
收藏
页数:12
相关论文
共 50 条
  • [11] Combination of Sjögren's syndrome and anti-Ku syndrome complicated by the development of mucosa-associated lymphoid tissue lymphoma: case review and systematic review of the literature
    Golovina, Oksana Andreevna
    Torgashina, Anna Vasilievna
    Gorodetskiy, Vadim Romanovich
    Sockol, Evgenia Vladimirovna
    Sagina, Elena Georgievna
    CLINICAL RHEUMATOLOGY, 2024, 43 (06) : 2145 - 2152
  • [12] Chemokines and lymphocyte homing in Sjögren's syndrome
    Liao, Jiahe
    Yu, Xinbo
    Huang, Ziwei
    He, Qian
    Yang, Jianying
    Zhang, Yan
    Chen, Jiaqi
    Song, Weijiang
    Luo, Jing
    Tao, Qingwen
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [13] Association between comorbidities and extraglandular manifestations in primary Sjögren’s syndrome: a multicenter cross-sectional study
    Yuying Zhang
    Mengtao Li
    Liyun Zhang
    Qin Li
    Pinting Yang
    Xiaodan Kong
    Xinwang Duan
    Miaojia Zhang
    Xiaomei Li
    Yongfu Wang
    Jian Xu
    Yanhong Wang
    Evelyn Hsieh
    Jiuliang Zhao
    Dong Xu
    Yan Zhao
    Xiaofeng Zeng
    Clinical Rheumatology, 2020, 39 : 2677 - 2688
  • [14] Sporadic Late-onset Nemaline Myopathy Associated with Sjögren's Syndrome
    Hamaguchi, Tsuyoshi
    Nishino, Ichizo
    Hirano, Yasuki
    Uchida, Nobuaki
    Fujita-Nakata, Michiyo
    Nakanishi, Megumi
    Sakai, Tomoyuki
    Asahina, Masato
    INTERNAL MEDICINE, 2024, 63 (19) : 2683 - 2687
  • [15] Increased risk of adverse gestational outcomes in pregnant women with primary Sjögren's syndrome
    Tan, Zhen
    Shao, Meilin
    Zhou, Yingbo
    Wang, Li
    Ma, Yan
    Xiang, Nan
    Yuan, Xiang
    Wang, Bin
    Xie, Xiangliang
    Zhou, Mingtao
    Wang, Yumin
    Li, Sidong
    Li, Xiaomei
    RMD OPEN, 2024, 10 (02):
  • [16] Lipid Metabolism: An Emerging Player in Sjögren's Syndrome
    Chang, Keni
    Luo, Peiming
    Guo, Zizhen
    Yang, Lufei
    Pu, Jincheng
    Han, Fang
    Cai, Feiyang
    Tang, Jianping
    Wang, Xuan
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2025, 68 (01)
  • [17] Operational characteristics of ultrasound in the diagnosis of Sjögren's syndrome
    Guavita-Navarro, D.
    Ibanez, C.
    Cajamarca-Baron, J.
    Rodriguez, D. E. Avendano
    Torres-Castiblanco, J. L.
    Barahona, A. B. Villamizar
    Burbano, H. D. Burbano
    Trujillo, A. Escobar
    Polo, J. F.
    Rojas-Villarraga, A.
    RADIOLOGIA, 2024, 66 (01): : 13 - 22
  • [18] Potential mechanisms and drug prediction of Rheumatoid Arthritis and primary Sjögren's Syndrome: A public databases-based study
    Wu, Li
    Wang, Qi
    Gao, Qi-chao
    Shi, Gao-xiang
    Li, Jing
    Fan, Fu-rong
    Wu, Jing
    He, Pei-Feng
    Yu, Qi
    PLOS ONE, 2024, 19 (02):
  • [19] Application of omics in Sjögren's syndrome
    He, Wenqin
    Lu, Yangyang
    Shi, Rongjing
    An, Qi
    Zhao, Jingwen
    Gao, Xinnan
    Zhang, Liyun
    Ma, Dan
    INFLAMMATION RESEARCH, 2023, 72 (12) : 2089 - 2109
  • [20] Investigative biological therapies for primary Sjögren's syndrome
    He, Shi-Hao
    Xuan, Yi-Yi
    Liang, Xu
    Guo, Kuang-Jin
    Wang, Yan
    Fu, Xiao-Ning
    Li, Tian-Fang
    ARCHIVES OF MEDICAL SCIENCE, 2024, 20 (02) : 506 - 516